ArticleJournal of migration and health2026
Delayed access to COVID-19 vaccination among migrants in Spain during 2021: an electronic health records-based study.
Article in Journal of migration and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In Spain, COVID-19 vaccination started on 27 December 2020, prioritizing people in long-term care facilities (LTCF), the elderly, and healthcare and essential workers. Different barriers to vaccination might have decreased or delayed uptake for migrant populations. We assessed the time to first COVID-19 vaccination by country of birth. Methods: We studied ≥12-year-olds registered within the Spanish healthcare administrative database between 27 December 2020 and 31 December 2021, not living in LTCF, with information on country of birth, and at least one COVID-19 vaccine dose. Using Weibull parametric survival models, we compared time to first vaccination between Spanish-born individuals and those born in: Western countries (WC), Eastern Europe (EE), North Africa and the Middle East (NAME), Sub-Saharan Africa (SSA), South-East Asia (SEA), Central America and the Caribbean (CAC), or South America (SA); adjusting for sex, age, priority vaccination group and region. Results: We included 26,720,450 individuals (Spanish-born: 86.1%; WC: 3.5%; EE: 0.4%; SSA: 0.6%; NAME: 2.1%; SEA: 0.6%; CAC: 1.4%; SA: 5.3%). Hazard Ratio for first vaccination was lower for all migrants' groups, WC: 0.68, EE: 0.45, SSA: 0.49, NAME: 0.56, SEA: 0.64, CAC: 0.65 and SA: 0.74, and median time to vaccination (days) was higher, WC: 164, EE: 185, SSA: 181, NAME: 174, SEA: 167, CAC: 166 and SA: 160, compared to 147 in Spanish-born. Conclusions: Migrants of any origin living in Spain accessed COVID-19 vaccination later than Spanish-born individuals. These findings highlight existing barriers increasing migrants' vulnerability during the pandemic and call for additional efforts to ensure equitable access.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.